サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：妊娠検査の世界市場-2023年～2030年
市場調査レポート
商品コード
1373380

妊娠検査の世界市場-2023年～2030年

Global Pregnancy Testing Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 185 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
妊娠検査の世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 185 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

検査概要

妊娠検査薬は、ヒト絨毛性ゴナドトロピン（HCG）と呼ばれる特別なホルモンを調べます。妊娠検査薬は、ヒト絨毛性ゴナドトロピン（HCG）を検出することによって機能します。血液中のHCG濃度は、妊娠初期には2～3日ごとに倍増し、妊娠が進行していることを示します。したがって、HCGが一定レベル以上あれば妊娠していることになります。

妊娠検査には大きく分けて尿検査と血液検査の2種類があります。血液検査は高価で、尿検査と同じ結果になりやすいため、ほとんど行われていません。血液検査は、妊娠ホルモンが体内にあるかどうかを検出するだけでなく、ホルモンの量も調べることができます。

市場力学：市場促進要因と市場抑制要因

妊娠検査キットの技術的進歩

技術の進歩と新製品のイントロダクションの増加は、市場の成長を高めると予想されます。自己妊娠検査に対する需要の増加が市場成長を高めると予想されます。

例えば、2022年8月9日、オーストラリアの新興企業Hoopsy社は、毎年何百万個もの使い捨てプラスチック製妊娠検査薬が埋立地に廃棄されるのを阻止する目的で、99％紙でできたリサイクル可能な妊娠検査薬を開発しました。

2023年2月7日、高品質で効果的な迅速検査を製造・販売するAbingdon Health plc社は、英国とアイルランドで初の唾液ベースの妊娠検査薬Salistickを発売するため、Salignostics社と新たな販売契約を締結しました。このように、様々な製品発売の増加が市場の成長を促進すると予想されます。

阻害要因

偽陽性

認識不足と不正確な結果が市場の妨げとなっています。ほとんどの検査キットは99％の精度を謳っています。しかし、精度は主にブランドや不適切な使用方法などの要因に左右されるため、誤った結果が出る可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 妊娠検査キットの技術的進歩
      • YY社
    • 抑制要因
      • 偽陽性
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 妊娠検査キット
    • ストリップ/ディプスティックおよびカード
    • デジタル機器
    • 中流キット
    • カセット
  • 不妊検査キット
    • ラインインジケーターキット
    • デジタル機器
    • その他

第8章 検査タイプ別

  • HCG血液
  • HCG尿
  • FSH尿
  • LH尿

第9章 販売チャネル別

  • オンライン販売
  • 婦人科・不妊クリニック
  • 薬局/ドラッグストア
  • ハイパーマーケット・スーパーマーケット
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Abbott Laboratories
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • BioMerieux SA
  • EKF Diagnostics Holdings plc
  • Atlas Medical
  • Quidel Corporation
  • BIOSYNEX SA
  • NG BIOTECH SAS
  • Axis Medicare
  • Cardinal Health Inc.
  • Thermo Fisher Scientific Inc.

第13章 付録

目次
Product Code: MDP1932

Overview

Pregnancy tests look for a special hormone called human chorionic gonadotropin (HCG) which is developed in a person's body during pregnancy. Pregnancy tests work by detecting human chorionic gonadotropin (HCG). The level of HCG in the blood doubles every 2 to 3 days during the first days of pregnancy, which indicates that the pregnancy is progressing. Thus, the presence of HCG above a certain level indicates pregnancy.

There are two main types of pregnancy tests, urine tests and blood tests. Blood tests are rarely done because they're expensive and tend to have the same result as a urine test. Blood test not only detects whether the pregnancy hormone is in the body, but can also determine how much of the hormone is present.

Market Dynamics: Drivers & Restraints

Technological advancements in pregnancy testing kits

The increase in technological advancements and the introduction of new products is expected to raise the market growth. The increase in the demand for self-pregnancy testing is expected to increase the market growth.

For instance, on August 9, 2022, Australian start-up Hoopsy created a recyclable pregnancy test that is 99 percent made out of paper, aiming to stop millions of single-use plastic versions ending up in landfill each year.

On February 7, 2023, Abingdon Health plc, manufacturer and distributor of high-quality and effective rapid tests, signed a new distribution agreement with Salignostics for the launch of Salistick the first saliva-based pregnancy test in the UK and Ireland. Thus, an increase in a variety of product launches is expected to drive the market growth.

Restraint

False positive results

Lack of awareness, and inaccurate results are hampering the market. Most of the test kits claim that they are 99% accurate. However, there is a possibility of false results, as the accuracy mainly depends on factors like the brand and improper usage.

Segment Analysis

The global pregnancy testing market is segmented based on product type, test type, distribution channel, and region.

Pregnancy test kits segment accounted for 39.5% of the market share

The pregnancy test kit detects the pregnancy hormone, human chorionic gonadotrophin (hCG), in the urine or serum. The test can be taken on the first day of the missing period. Continuous technological advancement in pregnancy test kits is a major factor expected to drive the market's growth. The demand for pregnancy test kits is increasing substantially owing to increasing incidences of unplanned pregnancies globally, driving the global pregnancy testing market.

For instance, on June 10, 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit that allows women to detect their pregnancy status themselves. With the launch of this test kit, the company marks its foray into the female healthcare segment.

Additionally, on April 14, 2022, Mankind Pharma's pregnancy test kit brand launched a new and advanced pregnancy detection test kit for the Indian market. With this launch, it strived to continually provide advanced testing solutions for confirming the pregnancy. Thus, an increase in the number of product launches is expected to raise the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global pregnancy testing market share

North American region accounted for the largest market share in 2021. The increased awareness among women leads to the increased demand for self-detecting pregnancy kits, growing fertility disorders, increased unplanned pregnancy rates, increased new product launches, and favorable government initiatives related to family planning.

For instance, according to the latest report in 2023 by the New York Times, the United States has long had one of the highest rates of unintended pregnancy in the world. It is estimated that 46 percent of pregnancies are now unintended.

Additionally, on July 14, 2023, 2San partnered with Proov to distribute their proprietary easy-to-use interpret, at-home fertility tests in select Hy-Vee stores across 8 states in the Midwest. Thus, the above factors are driving the market growth in the region.

COVID-19 Impact Analysis:

The COVID-19 has impacted the ventricular assist devices market positively. During this period there was a rapid increase in the sales of pregnancy kits and fertility kits. The increase in at-home test kit usage has increased the market growth. Thus, there in a rise in the pregnancy testing market growth during this period.

Competitive Landscape

The leading companies with a significant market share include: Abbott Laboratories, BioMerieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., and Thermo Fisher Scientific Inc.

Key Developments

  • In June 2022, PregaScreen, introduced an at-home pregnancy test kit that enables women to determine their pregnancy status, was introduced by Mylab Discovery Solutions.
  • On March 12, 2021, Lia, has introduced a flushable, biodegradable pregnancy test.

Why Purchase the Report?

  • To visualize the global pregnancy testing market segmentation based on product type, test type, distribution channel and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of pregnancy testing market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global pregnancy testing market report would provide approximately 62 tables, 59 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Test Type
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements in pregnancy testing kits
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. False positive results
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pregnancy Test Kits *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Strips/Dipsticks and Cards
    • 7.2.4. Digital Devices
    • 7.2.5. Midstream Kits
    • 7.2.6. Cassettes
  • 7.3. Fertility Test Kits
    • 7.3.1. Line indicator kits
    • 7.3.2. Digital devices
    • 7.3.3. Others

8. By Test Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 8.1.2. Market Attractiveness Index, By Test Type
  • 8.2. HCG Blood *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. HCG Urine
  • 8.4. FSH Urine
  • 8.5. LH Urine

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Online Sales *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Gynecology/ Fertility Clinics
  • 9.4. Pharmacies/Drugstores
  • 9.5. Hypermarkets and Supermarkets
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Laboratories *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. BioMerieux SA
  • 12.3. EKF Diagnostics Holdings plc
  • 12.4. Atlas Medical
  • 12.5. Quidel Corporation
  • 12.6. BIOSYNEX SA
  • 12.7. NG BIOTECH SAS
  • 12.8. Axis Medicare
  • 12.9. Cardinal Health Inc.
  • 12.10. Thermo Fisher Scientific Inc.

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us